TY - JOUR
T1 - Innate response to human cancer cells with or without IL-2 receptor common γ-chain function in NOD background mice lacking adaptive immunity
AU - Nishime, Chiyoko
AU - Kawai, Kenji
AU - Yamamoto, Takehiro
AU - Katano, Ikumi
AU - Monnai, Makoto
AU - Goda, Nobuhito
AU - Mizushima, Tomoko
AU - Suemizu, Hiroshi
AU - Nakamura, Masato
AU - Murata, Mitsuru
AU - Suematsu, Makoto
AU - Wakui, Masatoshi
N1 - Publisher Copyright:
Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved.
PY - 2015/8/15
Y1 - 2015/8/15
N2 - Immunodeficient hosts exhibit high acceptance of xenogeneic or neoplastic cells mainly due to lack of adaptive immunity, although it still remains to be elucidated how innate response affects the engraftment. IL-2R common γ-Chain (IL-2Rgc) signaling is required for development of NK cells and a subset of dendritic cells producing IFN-γ. To better understand innate response in the absence of adaptive immunity, we examined amounts of metastatic foci in the livers after intrasplenic transfer of human colon cancer HCT116 cells into NOD/SCID versus NOD/SCID/IL-2Rgc null (NOG) hosts. The intravital microscopic imaging of livers in the hosts depleted of NK cells and/or macrophages revealed that IL-2Rgc function critically contributes to elimination of cancer cells without the need for NK cells and macrophages. In the absence of IL-2Rgc, macrophages play a role in the defense against tumors despite the NOD Sirpa allele, which allows human CD47 to bind to the encoded signal regulatory protein a to inhibit macrophage phagocytosis of human cells. Analogous experiments using human pancreas cancer MIA PaCa-2 cells provided findings roughly similar to those from the experiments using HCT116 cells except for lack of suppression of metastases by macrophages in NOG hosts. Administration of mouse IFN-γ to NOG hosts appeared to partially compensate lack of IL-2Rgc-dependent elimination of transferred HCT116 cells. These results provide insights into the nature of innate response in the absence of adaptive immunity, aiding in developing tumor xenograft models in experimental oncology.
AB - Immunodeficient hosts exhibit high acceptance of xenogeneic or neoplastic cells mainly due to lack of adaptive immunity, although it still remains to be elucidated how innate response affects the engraftment. IL-2R common γ-Chain (IL-2Rgc) signaling is required for development of NK cells and a subset of dendritic cells producing IFN-γ. To better understand innate response in the absence of adaptive immunity, we examined amounts of metastatic foci in the livers after intrasplenic transfer of human colon cancer HCT116 cells into NOD/SCID versus NOD/SCID/IL-2Rgc null (NOG) hosts. The intravital microscopic imaging of livers in the hosts depleted of NK cells and/or macrophages revealed that IL-2Rgc function critically contributes to elimination of cancer cells without the need for NK cells and macrophages. In the absence of IL-2Rgc, macrophages play a role in the defense against tumors despite the NOD Sirpa allele, which allows human CD47 to bind to the encoded signal regulatory protein a to inhibit macrophage phagocytosis of human cells. Analogous experiments using human pancreas cancer MIA PaCa-2 cells provided findings roughly similar to those from the experiments using HCT116 cells except for lack of suppression of metastases by macrophages in NOG hosts. Administration of mouse IFN-γ to NOG hosts appeared to partially compensate lack of IL-2Rgc-dependent elimination of transferred HCT116 cells. These results provide insights into the nature of innate response in the absence of adaptive immunity, aiding in developing tumor xenograft models in experimental oncology.
UR - http://www.scopus.com/inward/record.url?scp=84938934017&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938934017&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1402103
DO - 10.4049/jimmunol.1402103
M3 - Article
C2 - 26170385
AN - SCOPUS:84938934017
SN - 0022-1767
VL - 195
SP - 1883
EP - 1890
JO - Journal of Immunology
JF - Journal of Immunology
IS - 4
ER -